Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company at its meeting held on May 14, 2007, has allotted 1,26,627 equity shares of Rs 2/- each of the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion by the FCCB holders for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 500,000 into the equity shares of the Company.
Consequently, the paid-up equity share capital of the Company has increased from 7,29,72,843 equity shares of Rs 2/- to 7,30,99,470 equity share of Rs 2/- each.